PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,471 stories, page 647 of 758

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Fluoxetine/Lamotrigine

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Redispersible nanoalum-adjuvanted hepatitis B vaccine microneedles with enhanced immunogenicity

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Transparent keratin nanocomposite films incorporating silver nanoparticles and aloe vera for wound management

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Traditional Buddhist Mindfulness Versus Secular Mindfulness-Based Cognitive Therapy for Residual Depressive Symptoms in Patients Treated for Depressive Disorder: A Pilot Randomized Controlled Trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Optimizing tourniquet pressures in knee arthroscopy: an international survey on current practice and a double-blind randomized trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Pharmacogenomic characterization of a uric acid metabolism-related signature associated with prognosis and drug sensitivity in gastric cancer

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Bovine Milk–Derived Extracellular Vesicles as Emerging Drug Delivery Platforms: Current Advances, Applications and Challenges

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical Pharmacists in Primary Care: A Real‐World Experience From São Paulo, Brazil

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The Permissible Use of the Pernkopf Atlas: A Single‐Case Qualitative Study of the Vienna Protocol

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Suzhou Fengbei Biotech Stock Co., Ltd. Class A – SSE:603334

TradingViewOriginal source
🌍Mediaechonous.comTier 2 · Direct publisher

EchoNous Expands Kosmos Clinical Capabilities with Vascular Auto Flow; Advanced Cardiac and Connectivity Tools

EchoNousOriginal source
🌍discoverynews.google.comTier 2 · Trade media

EMA: Amgen, Vifor Inflammatory Drug’s Benefits No Longer Outweigh Risks

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Viridian's Lumvoa for Thyroid Eye Disease (TED)

Eyewire+Original source
🌍discoverynews.google.comTier 3 · Aggregated media

This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In. -- Barrons.com

MoomooOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Pioneering projects to transform obesity care, backed by £85 million from government and industry

A dozen cutting-edge projects will benefit thousands of patients battling obesity across the UK.

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA approves Viridian eye drug, stoking competition with Amgen’s Tepezza

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Medpace (MEDP) Has a Backlog-and-Execution Engine Bigger Than a Biotech-Funding Scare

AlphaStreetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Argentina joins Chinese coronavirus vaccine trial

SONNA | Somali National News AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viridian Therapeutics announced that its innovative drug Lumvoa™ (generic name: veligrotug-vvze) has been approved by the U.S. Food and Drug Administration (FDA) and officially launched for the treatment of Thyroid Eye Disease (TED).

BitgetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Sunhawk Vision Biotech, Inc. – TPEX:7759

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Axsome Therapeutics (AXSM) Using Solriamfetol’s Phase 3 ADHD Trial To Redefine Its CNS Strategy?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

More Than 900,000 Bottles of Heart and Kidney Drugs Recalled: FDA Notice

mb.ntd.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lantheus stock falls after FDA rejects drug application

Investing.comOriginal source
🌍Industrymatinasbiopharma.comTier 1 · Company source

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

Matinas BioPharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

MarketWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Will Reportedly Conclude Abortion Pill Safety Review by September

Focus on the FamilyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Universe Pharmaceuticals Inc Announces Strategic Acquisition To Expand Pharmaceutical Patent Portfolio

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Swiss pharma at risk of US trade investigation, industry body says

1470 & 100.3 WMBDOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbbVie Inc Stock (ABBV) Closed Up by 3.53% on Jun 26: Facts Behind the Movement

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Swiss pharmaceutical industry faces potential US trade investigation

Crypto BriefingOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ALXN1840 Phase 3 data back NDA plan for Wilson disease, Monopar (NASDAQ: MNPR)

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Monopar’s Wilson disease drug shows stronger neurologic gains in Phase 3

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Universe Pharmaceuticals bets $10.8M on five China patents

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA declines to approve Sobi's gout therapy on concerns over manufacturing

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA warns 25 telehealth companies over claims about weight-loss drugs

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Norwich Loses Appeal Over FDA Delay of Its Generic Xifaxan Drug

Bloomberg Law NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In.

Barron'sOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

WHO issues guideline to curb environmental waste in pharmaceutical manufacturing

RAPS.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UNCY Stock On Track For Worst Day In About A Year Ahead Of FDA Decision On Lead Drug

Asianet NewsableOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Flexibility is the Secret to Modern Biotech Deals

BioPharm InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Shuts JJ Mahanagar Blood Bank Over Safety Violations

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Weekly Rundown: Definium's psychedelic drug delivers rapid relief in major depression in late-stage study

Drug Discovery NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Report: Lawmakers Say FDA Safety Review of Abortion Pill Could Be Complete by September

breitbart.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Critical Medicines Act’s Impact on Pharmaceutical Manufacturing and Supply Resilience in Europe

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Centanafadine Demonstrates Statistically Significant, Clinically Relevant Improvements in ADHD Symptoms

Pharmacy TimesOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Free Workshop – Measuring and Characterising Pharma

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Prescription Pulse

PoliticoOriginal source
🌍Mediavariational.aiTier 2 · Direct publisher

Variational AI featured in AWS’s “Canada’s AI Innovators” series

Variational AIOriginal source
🇺🇸Devicesorthopediatrics.comTier 1 · Company source

OSSIOfiber® Suture Anchors

OrthoPediatricsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Anna Berkenblit: Highlights from the ASCO Annual Meeting and Beyond

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tirzepatide and Emerging OSA Pharmacotherapy Expand the Treatment Toolkit, With Ashesha Mechineni, MD

Patient Care OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Maharashtra Suspends Operations Of Two Blood Centres Over Serious Regulatory Violations

Free Press JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why effectiveness is the ultimate measure of trust

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Swiss pharma at risk of US trade investigation, industry body says

The Mighty 790 KFGOOriginal source